Clinical Trial Update: Effects of IV Chloride Content on Outcomes

View source ↗

Summary

This clinical trial update examines how intravenous chloride content in balanced fluids impacts outcomes in systemic inflammatory response syndrome (SIRS), refe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Inflammatory Response Syndrome

Drugs mentioned

• 0.9% Sodium Chloride (Normal saline) (Sodium chloride solution 0.9%)
• Plasmalyte (Balanced electrolyte solution (Plasmalyte A))

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: SIRS, Balanced Fluids | Status: COMPLETED